• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性血色素沉着症:糖尿病和神经退行性疾病。

Aceruloplasminaemia: a disorder of diabetes and neurodegeneration.

机构信息

Department of Endocrinology and Diabetes, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.

Department of Gastroenterology, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.

出版信息

Intern Med J. 2017 Jan;47(1):115-118. doi: 10.1111/imj.13309.

DOI:10.1111/imj.13309
PMID:28076908
Abstract

Aceruloplasminaemia is an autosomal recessive disorder of iron metabolism which is characterised by diabetes, neurodegeneration and anaemia. It should be considered in the differential diagnosis of adult onset, antibody-negative diabetes associated with persistent mild anaemia and hyperferritinaemia and/or progressive neuropsychiatric impairments.

摘要

亚铁血黄素症是一种常染色体隐性遗传性铁代谢紊乱疾病,其特征是糖尿病、神经退行性变和贫血。在诊断成年起病、伴持续性轻度贫血和高血铁蛋白血症和/或进行性神经精神障碍的自身免疫阴性糖尿病时,应考虑该病。

相似文献

1
Aceruloplasminaemia: a disorder of diabetes and neurodegeneration.遗传性血色素沉着症:糖尿病和神经退行性疾病。
Intern Med J. 2017 Jan;47(1):115-118. doi: 10.1111/imj.13309.
2
Aceruloplasminaemia: a rare but important cause of iron overload.无血浆铜蓝蛋白血症:一种罕见但重要的铁过载病因。
BMJ Case Rep. 2015 May 14;2015:bcr2014207541. doi: 10.1136/bcr-2014-207541.
3
Effectiveness of oral iron chelator treatment with deferasirox in an aceruloplasminemia patient with a novel ceruloplasmin gene mutation.口服铁螯合剂地拉罗司治疗一名携带新型铜蓝蛋白基因突变的无铜蓝蛋白血症患者的疗效。
Intern Med. 2013;52(13):1527-30. doi: 10.2169/internalmedicine.52.0102. Epub 2013 Jul 1.
4
Aceruloplasminaemia with progressive atrophy without brain iron overload: treatment with oral chelation.无脑铁过载的进行性萎缩性血浆铜蓝蛋白缺乏症:口服螯合治疗
J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):467-70. doi: 10.1136/jnnp.2007.120568. Epub 2007 Oct 2.
5
Aceruloplasminaemia: a family with a novel mutation and long-term therapy with deferasirox.血浆铜蓝蛋白缺乏症:一个具有新突变并接受地拉罗司长期治疗的家族。
Horm Metab Res. 2015 Apr;47(4):303-8. doi: 10.1055/s-0034-1383650. Epub 2014 Aug 4.
6
Case 35-2020: A 59-Year-Old Woman with Type 1 Diabetes Mellitus and Obtundation.病例35 - 2020:一名患有1型糖尿病且意识不清的59岁女性。
N Engl J Med. 2020 Nov 12;383(20):1974-1983. doi: 10.1056/NEJMcpc2002412.
7
New mutation of the ceruloplasmin gene in the case of a neurologically asymptomatic patient with microcytic anaemia, obesity and supposed Wilson's disease.神经学无症状的小细胞低色素性贫血、肥胖和疑似威尔逊病患者的铜蓝蛋白基因突变。
BMC Gastroenterol. 2020 Apr 7;20(1):95. doi: 10.1186/s12876-020-01237-8.
8
Combination-therapy with concurrent deferoxamine and deferiprone is effective in treating resistant cardiac iron-loading in aceruloplasminaemia.去铁胺与地拉罗司联合治疗对无血浆铜蓝蛋白血症患者难治性心脏铁过载有效。
Br J Haematol. 2015 Nov;171(3):430-2. doi: 10.1111/bjh.13401. Epub 2015 Apr 8.
9
Central nervous system involvement in a rare genetic iron overload disorder.中枢神经系统受累于一种罕见的遗传性铁过载疾病。
Neth J Med. 2010 Oct;68(10):316-8.
10
Deferasirox Might Be Effective for Microcytic Anemia and Neurological Symptoms Associated with Aceruloplasminemia: A Case Report and Review of the Literature.去铁胺可能对与血浆铜蓝蛋白缺乏症相关的小细胞贫血和神经症状有效:一例报告及文献综述
Intern Med. 2020 Jul 15;59(14):1755-1761. doi: 10.2169/internalmedicine.4178-19. Epub 2020 Apr 2.

引用本文的文献

1
The Role of Iron in Atherosclerosis in Apolipoprotein E Deficient Mice.铁在载脂蛋白E缺乏小鼠动脉粥样硬化中的作用。
Front Cardiovasc Med. 2022 May 20;9:857933. doi: 10.3389/fcvm.2022.857933. eCollection 2022.
2
Mitochondrial iron metabolism and neurodegenerative diseases.线粒体铁代谢与神经退行性疾病。
Neurotoxicology. 2022 Jan;88:88-101. doi: 10.1016/j.neuro.2021.11.003. Epub 2021 Nov 5.
3
Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders.脑铁沉积神经退行性疾病(NBIA)中的新兴疾病修饰疗法。
Front Neurol. 2021 Apr 15;12:629414. doi: 10.3389/fneur.2021.629414. eCollection 2021.
4
Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports.螯合疗法对铜蓝蛋白血症临床病程的影响:聚合病例报告分析。
Orphanet J Rare Dis. 2020 Apr 25;15(1):105. doi: 10.1186/s13023-020-01385-w.
5
Deferasirox Might Be Effective for Microcytic Anemia and Neurological Symptoms Associated with Aceruloplasminemia: A Case Report and Review of the Literature.去铁胺可能对与血浆铜蓝蛋白缺乏症相关的小细胞贫血和神经症状有效:一例报告及文献综述
Intern Med. 2020 Jul 15;59(14):1755-1761. doi: 10.2169/internalmedicine.4178-19. Epub 2020 Apr 2.
6
Aceruloplasminemia: Waiting for an Efficient Therapy.无铜蓝蛋白血症:等待有效治疗方法
Front Neurosci. 2018 Dec 4;12:903. doi: 10.3389/fnins.2018.00903. eCollection 2018.